Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
1997-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2001-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2001511141-A |
titleOfInvention |
Brain damage of 1- [4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyrid-1-yl] -2- (6,7-dimethoxynaphth-2-yl) ethane For preparing drugs intended for treating nervous disorders |
abstract |
(57) [Summary]nThe present invention relates to 1- [4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyrid-1-yl] -2- (6,7-dimethoxynaphth-2-yl) ethane The invention relates to the use of (I) for preparing a medicament for treating and / or preventing cerebral and neurological disorders. |
priorityDate |
1997-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |